This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tan, W. Articles by Lin, D.-X. Search for Related Content PubMed PubMed Citation Articles by Tan, W. Articles by Lin, D.-X.

Impact of Genetic Polymorphisms in Cytochrome P450 2E1 and Glutathione S-Transferases M1, T1, and P1 on Susceptibility to Esophageal Cancer among High-Risk Individuals in China¹

Department of Chemical Etiology and Carcinogenesis, Cancer Institute, Chinese Academy of Medical Sciences and Beijing Union Medical College, Beijing 100021, China [W. T., N. S., G-Q. W., H-J. T., D-X. L.]; Department of Medical Statistics, Sun Yat-sen University of Medical Sciences, Guanzhou 510060, China [Q. L.]; and Division of Molecular Epidemiology, National Center for Toxicological Research, Jefferson, Arkansas 72079 [F. F. K.]

Esophageal cancer, which is prevalent in China, is believed to be induced by environmental carcinogens such as nitrosamines and other agents. The disproportionate geographical distribution of this cancer among individuals suggests a role for gene-environment interactions in developing the disease. We have shown in our preliminary study that a genetic polymorphism in cytochrome P450 2E1 (CYP2E1) that is known to activate nitrosamines may be a susceptibility factor involved in the early events leading to the development of esophageal cancer (Lin et al., Cancer Epidemiol. Biomark. Prev., 7: 1013–1018, 1998). This relatively larger study was conducted to compare the results with our previous findings. One hundred and fifty cases with esophageal cancer, 146 cases with esophageal dysplasia, and 150 normal controls were residents of Linxian, China, a high-risk area. Genomic DNA samples were assayed for restriction fragment length polymorphisms in the CYP2E1 and GSTP1 loci by PCR amplification followed by digestion with RsaI and Alw26I, respectively. Deletion of the GSTM1 and GSTT1 genes was detected by multiplex PCR. The distribution of CYP2E1 c1/c1 allele frequency was found to be significantly different between controls (44.0%) and cases with cancer (71.3%) or cases with dysplasia (70.6%; P < 0.0001). Individuals having the c1/c1 genotype were at a 3.1-fold [95% confidence interval (CI), 2.4–3.9] increased risk of developing dysplasia and a 3.2-fold (95% CI, 2.5–4.1) increased risk of developing squamous cell carcinoma of the esophagus. Although polymorphisms in the GSTT1 and GSTP1 were not significantly different between cases with cancer or cases with dysplasia and controls, the frequency of the GSTM1 non-null (+/+ and +/0) genotypes appeared to be overrepresented in cases with cancer compared with controls (odds ratio, 2.3; 95% CI, 1.8–3.0). Furthermore, a joint effect of the CYP2E1 c1/c1 genotype and GSTM1 non-null genotype on the cancer risk was observed, showing an odds ratio of 8.5 (95% CI, 3.7–19.9). These results demonstrate that CYP2E1 and perhaps GSTM1 are genetic determinants in the development of squamous cell carcinoma of the esophagus.

This article has been cited by other articles:

				L.-C. Lin, W.-J. Chen, Y.-M. Chiung, T.-S. Shih, and P.-C. Liao Association between GST Genetic Polymorphism and Dose-Related Production of Urinary Benzene Metabolite Markers, trans, trans-Muconic Acid and S-Phenylmercapturic Acid Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1460 - 1469. [Abstract] [Full Text] [PDF]

				A. Rossini, D.C.M. Rapozo, S.C. Soares Lima, D.P. Guimaraes, M.A. Ferreira, R. Teixeira, C.D.P. Kruel, S.G.S. Barros, N.A. Andreollo, R. Acatauassu, et al. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population Carcinogenesis, December 1, 2007; 28(12): 2537 - 2542. [Abstract] [Full Text] [PDF]

				S. Kury, B. Buecher, S. Robiou-du-Pont, C. Scoul, V. Sebille, H. Colman, C. Le Houerou, T. Le Neel, J. Bourdon, R. Faroux, et al. Combinations of Cytochrome P450 Gene Polymorphisms Enhancing the Risk for Sporadic Colorectal Cancer Related to Red Meat Consumption Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1460 - 1467. [Abstract] [Full Text] [PDF]

				J. L. Shepard, J. F. Amatruda, D. Finkelstein, J. Ziai, K. R. Finley, H. M. Stern, K. Chiang, C. Hersey, B. Barut, J. L. Freeman, et al. A mutation in separase causes genome instability and increased susceptibility to epithelial cancer Genes & Dev., January 1, 2007; 21(1): 55 - 59. [Abstract] [Full Text] [PDF]

				Y. Li, X. Zhang, G. Huang, X. Miao, L. Guo, D. Lin, and S.-H. Lu Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1) and its related risk to esophageal squamous cell carcinoma Carcinogenesis, April 1, 2006; 27(4): 798 - 802. [Abstract] [Full Text] [PDF]

				J. Zhang, Y. Cui, G. Kuang, Y. Li, N. Wang, R. Wang, W. Guo, D. Wen, L. Wei, F. Yu, et al. Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma Carcinogenesis, December 1, 2004; 25(12): 2479 - 2485. [Abstract] [Full Text] [PDF]

				J. Zhang, W. A. Schulz, Y. Li, R. Wang, R. Zotz, D. Wen, D. Siegel, D. Ross, H. E. Gabbert, and M. Sarbia Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population Carcinogenesis, May 1, 2003; 24(5): 905 - 909. [Abstract] [Full Text] [PDF]

				A. Yokoyama, H. Kato, T. Yokoyama, T. Tsujinaka, M. Muto, T. Omori, T. Haneda, Y. Kumagai, H. Igaki, M. Yokoyama, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma Carcinogenesis, November 1, 2002; 23(11): 1851 - 1859. [Abstract] [Full Text] [PDF]

				L. Le Marchand, T. Donlon, A. Seifried, and L. R. Wilkens Red Meat Intake, CYP2E1 Genetic Polymorphisms, and Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1019 - 1024. [Abstract] [Full Text] [PDF]

				J.-Q. He, J. Ruan, J. E. Connett, N. R. Anthonisen, P. D. Pare, and A. J. Sandford Antioxidant Gene Polymorphisms and Susceptibility to a Rapid Decline in Lung Function in Smokers Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 323 - 328. [Abstract] [Full Text] [PDF]

				C. Gao, T. Takezaki, J. Wu, Z. Li, J. Wang, J. Ding, Y. Liu, X. Hu, T. Xu, K. Tajima, et al. Interaction between Cytochrome P-450 2E1 Polymorphisms and Environmental Factors with Risk of Esophageal and Stomach Cancers in Chinese Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 29 - 34. [Abstract] [Full Text]

				G. D. Stoner and A. Gupta Etiology and chemoprevention of esophageal squamous cell carcinoma Carcinogenesis, November 1, 2001; 22(11): 1737 - 1746. [Abstract] [Full Text] [PDF]

				S. C. Chen, L. Zhou, X. Ding, and S. S. Mirvish Depentylation of the Rat Esophageal Carcinogen, Methyl-n-pentylnitrosamine, by Microsomes from Various Human and Rat Tissues and by Cytochrome P450 2A3 Drug Metab. Dispos., September 1, 2001; 29(9): 1221 - 1228. [Abstract] [Full Text] [PDF]